The US government has eased restrictions on medical cannabis use, reclassifying the drug to allow wider patient access and expanded research into its safety and effectiveness.
Marijuana has been reclassified from Schedule I to Schedule III, a move that expands patients' access to treatments and empowers doctors to make better-informed healthcare decisions.
The Department of Justice said the move follows up on US President Donald Trump's executive order aimed at increasing research into medical marijuana.
A new hearing, beginning June 29, 2026, will provide a timely and legally compliant pathway to evaluate broader changes to marijuana's status under federal law.
